% alzhub.org library filter
% Source: https://alzhub.org/research?author=Ovod+V&access=free
% 6 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{janelidze2024-39068669,
  author  = {Janelidze, S. and Barthélemy, N. R. and Salvadó, G. and Schindler, S. E. and Palmqvist, S. and Mattsson-Carlgren, N. and Braunstein, J. B. and Ovod, V. and Bollinger, J. G. and He, Y. and Li, Y. and Raji, C. A. and others},
  title   = {{Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment}},
  journal = {JAMA Neurology},
  year    = {2024},
  doi     = {10.1001/jamaneurol.2024.2619},
  pmid    = {39068669},
  url     = {https://doi.org/10.1001/jamaneurol.2024.2619}
}

@article{janelidze2021-34542571,
  author  = {Janelidze, S. and Teunissen, C. E. and Zetterberg, H. and Allué, J. A. and Sarasa, L. and Eichenlaub, U. and Bittner, T. and Ovod, V. and others},
  title   = {{Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2021.3180},
  pmid    = {34542571},
  url     = {https://doi.org/10.1001/jamaneurol.2021.3180}
}

@article{li2022-34906975,
  author  = {Li, Y. and Schindler, S. E. and Bollinger, J. G. and Ovod, V. and Mawuenyega, K. G. and Weiner, M. W. and Shaw, L. M. and Masters, C. L. and others},
  title   = {{Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000013211},
  pmid    = {34906975},
  url     = {https://doi.org/10.1212/wnl.0000000000013211}
}

@article{delrieu2023-37872582,
  author  = {Delrieu, J. and Vellas, B. and Guyonnet, S. and Cantet, C. and Ovod, V. and Li, Y. and Bollinger, J. and Bateman, R. and others},
  title   = {{Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2023},
  doi     = {10.1186/s13195-023-01325-3},
  pmid    = {37872582},
  url     = {https://doi.org/10.1186/s13195-023-01325-3}
}

@article{schindler2019-31371569,
  author  = {Schindler, S. E. and Bollinger, J. G. and Ovod, V. and Mawuenyega, K. G. and Li, Y. and Gordon, B. A. and Holtzman, D. M. and Morris, J. C. and others},
  title   = {{High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis}},
  journal = {Neurology},
  year    = {2019},
  doi     = {10.1212/wnl.0000000000008081},
  pmid    = {31371569},
  url     = {https://doi.org/10.1212/wnl.0000000000008081}
}

@article{meeker2024-38505230,
  author  = {Meeker, K. L. and Luckett, P. H. and Barthélemy, N. R. and Hobbs, D. A. and Chen, C. and Bollinger, J. and Ovod, V. and Flores, S. and others},
  title   = {{Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease}},
  journal = {Brain communications},
  year    = {2024},
  doi     = {10.1093/braincomms/fcae081},
  pmid    = {38505230},
  url     = {https://doi.org/10.1093/braincomms/fcae081}
}